Skip to Content

T. Rowe Price Health Care ETF (TMED US)

TMED US$34.72

20 minute delayed

Today ▲ 0.46%
1 year return ▲ 20.39%
Volume 400
Div yield —
PE ratio —
52 week range
27.50 36.92

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.

Share price activity

Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
Last (Price)
34.72
Change
▲ 0.16 (0.46)
Bid / Ask
26.98 - 34.87
Volume
400
Turnover
10,434
Open
34.81
Day Range
34.72 - 34.81
VWAP
34.78
Prev Close
34.56
Last Trade
28/10 12:54pm

Fund profile

Displays who issues the fund, how it is structured and invests, its Morningstar category and benchmark, size, headline costs and dates, sourced from Morningstar. Fund size counts every class of the fund; ETF net assets is this listing alone.

Fund size

$34.0M

OCT 2026

Distributions

Annually

Since inception

1.4 yrs

JUN 2025

Legal name
T. Rowe Price Health Care ETF
Issuer
T. Rowe Price
Type
Exchange-Traded Fund
Structure
Open Ended Investment Company
Management style
Actively managed
Morningstar category
Health
Category index
Morningstar US Health TR USD
Benchmark
N/A
ETF net assets
$34.0M
Units on issue
1.0M
Management fee
0.44% p.a.
Domicile
United States
Base currency
USD
Inception
11 JUN 2025
Listed
12 JUN 2025

Objective and strategy

The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.

Asset allocation

Displays how the fund is split between shares, bonds, cash and other assets, sourced from Morningstar.

US equity 96.20%Non-US equity 3.71%

Asset class Net % Long % Short %
Equity 99.91 99.91 0.00
Bond 0.00 0.00 0.00
Cash 0.09 0.09 0.00
Other 0.00 0.00 0.00

Sector exposure

Displays the share of the fund held in each sector, sourced from Morningstar.

Cyclical 0.00%Sensitive 0.00%Defensive 100.00%

Basic Materials
0.00%
Consumer Cyclical
0.00%
Financial Services
0.00%
Real Estate
0.00%
Communication Services
0.00%
Energy
0.00%
Industrials
0.00%
Technology
0.00%
Consumer Defensive
0.00%
Healthcare
100.00%
Utilities
0.00%

Region exposure

Displays the share of the fund held in each region, sourced from Morningstar.

Developed markets 99.68%Emerging markets 0.33%

North America
96.87%
Latin America
0.00%
United Kingdom
0.21%
Europe Developed
2.59%
Europe Emerging
0.00%
Africa / Middle East
0.00%
Japan
0.00%
Australasia
0.00%
Asia Developed
0.00%
Asia Emerging
0.33%

Country exposure

Displays the twelve countries the fund holds most of, sourced from Morningstar.
United States
96.29%
Switzerland
1.78%
Germany
0.63%
Canada
0.58%
China
0.33%
United Kingdom
0.21%
Italy
0.19%

Style box

Displays where the fund's shareholdings sit on Morningstar's style box: size (large, mid, small) down and investment style (value, blend, growth) across, sourced from Morningstar.
Style
Mid Blend
Average moat
Moderate

Size score

130

Small Mid Large

Value-growth score

151

Value Blend Growth

Economic moat

Wide 44%Narrow 46%None 9%

Market capitalisation

Displays the share of the fund's shareholdings in giant, large, mid, small and micro cap companies, sourced from Morningstar.
Giant
6.26%
Large
23.05%
Mid
27.30%
Small
25.04%
Micro
18.35%

Giant 6%Large 23%Mid 27%Small 25%Micro 18%

Average market cap
$22.80B
Number of holdings
120
Shares held
113

Portfolio statistics · 23 OCT 2026

Displays the valuation, yield, size, concentration and quality of the fund's shareholdings taken together (trailing twelve months), sourced from Morningstar.
Price / earnings
31.10
Price / book
3.66
Price / sales
1.59
Price / cash flow
19.74
Dividend yield
0.42%
Assets in top 10
38.69%
Return on equity
8.51%
Net margin
12.12%

Top holdings · top 10 = 39.37% of assets

Displays the fund's ten largest holdings and their weight in the portfolio, sourced from Morningstar.
Holding % Weight First bought Market value Currency Units held Sector Country
Eli Lilly and Co LLY 6.17 JUN 2025 2.1M USD 1,738 Healthcare United States
Alnylam Pharmaceuticals Inc ALNY 5.78 JAN 2026 1.9M USD 7,589 Healthcare United States
UnitedHealth Group Inc UNH 5.27 JUN 2025 1.8M USD 4,686 Healthcare United States
Thermo Fisher Scientific Inc TMO 3.78 SEP 2025 1.3M USD 1,855 Healthcare United States
Cencora Inc COR 3.44 JUN 2025 1.1M USD 3,734 Healthcare United States
Insulet Corp PODD 3.20 JUL 2025 1.1M USD 8,035 Healthcare United States
Gilead Sciences Inc GILD 3.17 JUN 2025 1.1M USD 6,979 Healthcare United States
Agilent Technologies Inc A 3.03 JUN 2025 1.0M USD 5,770 Healthcare United States
Intuitive Surgical Inc ISRG 2.81 AUG 2026 935,649 USD 2,270 Healthcare United States
Elanco Animal Health Inc ELAN 2.72 JUN 2025 905,779 USD 40,061 Healthcare United States

Trailing returns · 30 SEP 2026

Displays total returns after fees at net asset value, the return at the ASX market price, the return before fees, and where the fund ranks among funds in its Morningstar category, sourced from Morningstar.

Fund (NAV) Market price

1M

-4.4

3M

-0.8

6M

17.0

YTD

14.1

1Y

27.7

Period Fund (NAV) % Market price % Before fees % Rank in category
1 month -4.38 -4.22 -4.34 80 / 176
3 months -0.76 -0.62 -0.65 77 / 175
6 months 17.00 17.33 17.26 45 / 171
Year to date 14.08 14.19 14.46 43 / 171
1 year 27.70 27.91 28.26 45 / 170

Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.

Risk statistics · 30 SEP 2026

Displays how the fund has moved relative to its category index: alpha (return beyond the index), beta (sensitivity to it), R-squared (how much the index explains), volatility and risk-adjusted returns, sourced from Morningstar.
1 year 3 years 5 years 10 years
Alpha 15.44 — — —
Beta 0.52 — — —
R-squared 21.95 — — —
Standard deviation 15.65 — — —
Sharpe ratio 1.41 — — —
Sortino ratio 2.87 — — —
Tracking error 15.44 — — —
Information ratio 0.71 — — —
Upside capture % 82.95 — — —
Downside capture % -40.67 — — —
Maximum drawdown % -5.11 — — —

Measured against MSCI ACWI NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.

Portfolio risk score

Displays Morningstar's Portfolio Risk Score for the fund's holdings, how closely the ETF tracks its index day to day, the estimated cost of holding it against the index, the cost of trading it at market size, and its best and worst quarters since inception, sourced from Morningstar.

Risk score

74.8

Cash 0
Global shares 100

Morningstar Portfolio Risk Score at 30 SEP 2026.

Best quarter
20.54% · NOV 2025
Worst quarter
-2.39% · MAR 2026

Fees and costs

Displays the fund's ongoing costs as a percentage of assets per year: the PDS management fees and costs, performance fee and transaction costs that make up the total cost ratio (the RG 97 forward estimate, and what was charged last financial year), and the buy / sell spread, sourced from Morningstar.
Management fees and costs
0.44% p.a.
PDS dated
1 MAR 2026

Distributions

Displays the most recent distribution paid per unit and its key dates, sourced from Morningstar.
Latest distribution
0.1616
Ex Date
23 DEC 2025
Record Date
23 DEC 2025
Pay Date
26 DEC 2025
NAV at ex date
29.78

Distributions by year

Displays the total distributions paid per unit in each calendar year, sourced from Morningstar.

2024

0.2

Year Per unit ($)
2024 0.1616

Distribution history

Displays the most recent distributions by ex date, sourced from Morningstar.
Ex Date Per unit ($)
23 DEC 2025 0.1616

Sustainability rating · 31 AUG 2026

Displays the Morningstar Sustainability Rating (1 to 5 globes, more is better) and the portfolio ESG risk score behind it (lower is less risk), against the average of the fund's global category, sourced from Morningstar and Sustainalytics.

Average

ESG risk score

20.98

Negligible Low Medium High Severe

Category average 21.96

Rank in category
50th percentile of 594 funds
Environmental risk
1.80
Social risk
7.41
Governance risk
3.30
Portfolio covered
92.9%

ESG risk of holdings

Displays the share of the covered portfolio held in companies with negligible, low, medium, high and severe ESG risk, sourced from Morningstar and Sustainalytics.
Negligible
5.35%
Low
38.94%
Medium
34.93%
High
20.44%
Severe
0.33%

5.51% of assets are in companies with high or severe controversies.

Carbon · 31 AUG 2026

Displays the portfolio carbon risk score (lower is less exposure to the transition to a low-carbon economy), the share of the portfolio in companies with fossil fuel revenue, and whether the fund earns Morningstar's Low Carbon Designation, sourced from Morningstar and Sustainalytics.

Carbon risk score

2.41

Low Medium High Severe

Category average 2.74

Carbon risk
Low Risk
Rank in category
39th percentile of 313 funds
Fossil fuel involvement
0.00%
Category average
0.16%
Low Carbon Designation
Yes
Portfolio covered
92.4%

Fund managers

Displays the people Morningstar lists as managers of the fund, sourced from Morningstar.
  • Sal Rais

Tenure

Displays how long the managers have run the fund: the average and longest tenure, who has served longest, the latest appointment and how many other funds the team manages, sourced from Morningstar.
Number of managers
1
Average tenure
1.3 years
Longest tenure
1.3 years
Longest serving
Sal Rais · since 11 JUN 2025
Most recent appointment
Sal Rais · since 11 JUN 2025
Managed since
11 JUN 2025
Other funds managed
1
Displays all company announcements released by the company to the exchange, sourced from Morningstar.

Announcements

Announcements are available for ASX-listed companies only.

Opinion

No opinions for this company yet.

Action

No actions for this company yet.

image description

Relevant suggested news and content from the site

Back to top